Metabolic shifts in residual breast cancer drive tumor recurrence

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Investigation

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI89914PMID 28504653PMCID PMC5451224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

  2016cited by this paper
• Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment

  2016cited by this paper
• Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

  2014cited by this paper
• Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future

  2013cited by this paper
• The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy

  2013influential reference
• The biophysics and cell biology of lipid droplets

  2013cited by this paper
• Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.

  2013cited by this paper
• Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development

  2013cited by this paper
• A community-driven global reconstruction of human metabolism

  2013cited by this paper
• Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium

  2013cited by this paper
• Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells.

  2012cited by this paper
• Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

  2012cited by this paper
• Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort

  2012cited by this paper
• Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study

  2012cited by this paper
• Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study

  2012cited by this paper
• How genetically engineered mouse tumor models provide insights into human cancers.

  2011cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Framework models of tumor dormancy from patient-derived observations.

  2011cited by this paper
• Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes

  2010cited by this paper
• Progesterone induces adult mammary stem cell expansion

  2010cited by this paper
• Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium

  2010cited by this paper
• Vitamin Supplement Use During Breast Cancer Treatment and Survival: A Prospective Cohort Study

  2010cited by this paper
• Oxidative stress, inflammation, and cancer: how are they linked?

  2010cited by this paper
• SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation

  2010cited by this paper
• SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation

  2009cited by this paper
• Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.

  2009cited by this paper
• Prevalence and predictors of antioxidant supplement use during breast cancer treatment

  2009cited by this paper
• Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.

  2009cited by this paper
• Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras

  2008influential reference
• Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

  2007cited by this paper
• Models, mechanisms and clinical evidence for cancer dormancy

  2007influential reference
• Up-regulation of Acetyl-CoA Carboxylase α and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells*

  2007cited by this paper
• Purification and unique properties of mammary epithelial stem cells

  2006cited by this paper
• Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy

  2006cited by this paper
• Generation of a functional mammary gland from a single stem cell

  2006cited by this paper
• Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

  2006cited by this paper
• Uncovering transcriptional regulation of metabolism by using metabolic network topology.

  2005cited by this paper
• Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice

  2004cited by this paper
• HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

  2004cited by this paper
• Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Variance stabilization applied to microarray data calibration and to the quantification of differential expression

  2002cited by this paper
• Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

  2002cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues.

  1999cited by this paper
• Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions.

  1998cited by this paper
• Risk factors in breast-conservation therapy.

  1994cited by this paper
• Reproductive factors and breast cancer.

  1993cited by this paper
• Reconstitution of hepatic microsomal stearoyl-coenzyme A desaturase system from solubilized components.

  1972cited by this paper
• Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments

  year unknowncited by this paper

• Picosecond infrared laser mass spectrometry for 10-second identification of lymphoproliferative imposter tumours in patient-derived xenografts

  2026cites this paper
• Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model

  2025cites this paper
• The pleiotropic roles of non-hormonal receptor basigin and regulatory microRNAs in breast cancer

  2025cites this paper
• Advances in targeting glycogen synthase kinase 3β for diabetes therapy.

  2025cites this paper
• Metabolic Regulation of Ferroptosis in Breast Cancer

  2025influential citation
• Cancer Dormancy and Metabolism: From Molecular Insights to Translational Opportunities.

  2025cites this paper
• High CD36 Expression Predicts Aggressive Invasion and Recurrence in Oral Squamous Cell Carcinoma

  2025cites this paper
• Achievements applications and future of nanomaterials in cancer immunotherapy.

  2025cites this paper
• Understanding Tumor Dormancy: from Experimental Models to Mechanisms and Therapeutic Strategies

  2025cites this paper
• Genetic advancements in breast cancer treatment: a review

  2025cites this paper
• CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance

  2025cites this paper
• Clinical significance of lipid pathway-targeted therapy in breast cancer

  2025cites this paper
• Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer

  2025cites this paper
• Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer

  2025cites this paper
• The Key Role of COA6 in Pancreatic Ductal Adenocarcinoma: Metabolic Reprogramming and Regulation of the Immune Microenvironment

  2025cites this paper
• Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics

  2024cites this paper
• p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress

  2024influential citation
• The effect of fatty acids in tumor development and nutrition therapy for cancer

  2024cites this paper
• Modulation of the local angiotensin II: Augmentation of ferroptosis and radiosensitivity in nasopharyngeal carcinoma via the HIF-1α-HILPDA axis.

  2024cites this paper
• NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer.

  2024cites this paper
• Lung cancer and obesity: A contentious relationship (Review)

  2024cites this paper
• Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes

  2024cites this paper
• Longitudinal multiomics analysis of aggressive pituitary neuroendocrine tumors: comparing primary and recurrent tumors from the same patient, reveals genomic stability and heterogeneous transcriptomic profiles with alterations in metabolic pathways

  2024cites this paper
• mTOR in metabolic homeostasis and disease.

  2024cites this paper
• In vivo spectroscopy to concurrently characterize five metabolic and vascular endpoints relevant to aggressive breast cancer.

  2024cites this paper
• FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer

  2024cites this paper
• Cancer radioresistance is characterized by a differential lipid droplet content along the cell cycle

  2024cites this paper
• The molecular crosstalk of the hippo cascade in breast cancer: A potential central susceptibility.

  2024cites this paper
• Persisting cancer cells are different from bacterial persisters.

  2024cites this paper
• Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer

  2024cites this paper
• An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism

  2024cites this paper
• Image‐guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake

  2024cites this paper
• Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer

  2023cites this paper
• The lipid metabolism remodeling: A hurdle in breast cancer therapy.

  2023cites this paper
• Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation

  2023cites this paper
• Endocrine‐disrupting compounds and metabolomic reprogramming in breast cancer

  2023cites this paper
• Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

  2023cites this paper
• Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature

  2023cites this paper
• FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer

  2023cites this paper
• Therapeutic strategies targeting metabolic characteristics of cancer cells.

  2023cites this paper
• Immune cells in residual disease and recurrence.

  2023cites this paper
• Suppressing cancer by damaging cancer cell DNA using LED irradiation.

  2023cites this paper
• Distinct Cholesterol Localization in Glioblastoma Multiforme Revealed by Mass Spectrometry Imaging

  2023cites this paper
• RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence

  2023cites this paper
• Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer

  2023cites this paper
• Involvement of redox signalling in tumour cell dormancy and metastasis

  2023cites this paper
• The role of cancer cell bioenergetics in dormancy and drug resistance

  2023cites this paper
• Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer

  2022cites this paper
• Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy

  2022cites this paper
• Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism

  2022cites this paper
• Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres

  2022cites this paper
• In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence

  2022cites this paper
• NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival

  2022cites this paper
• Relationship between metabolic reprogramming and drug resistance in breast cancer

  2022cites this paper
• CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope

  2022cites this paper
• Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast Cancers

  2022cites this paper
• Recent insights into the effects of metabolism on breast cancer cell dormancy

  2022cites this paper
• Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas

  2022cites this paper
• Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer

  2022cites this paper
• Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients

  2022cites this paper
• Single Organoids Droplet-Based Staining Method for High-End 3D Imaging of Mammary Organoids.

  2022cites this paper
• Cancer Recurrence and Omics: Metabolic Signatures of Cancer Dormancy Revealed by Transcriptome Mapping of Genome-Scale Networks

  2022cites this paper
• Modification of Single Cells Within Mouse Mammary Gland Derived Acini via Viral Transduction.

  2022cites this paper
• Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance

  2022cites this paper
• Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies

  2022cites this paper
• A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo

  2022influential citation
• Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer

  2022cites this paper
• Redox Control of the Dormant Cancer Cell Life Cycle

  2021cites this paper
• In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer

  2021cites this paper
• Understanding the subjective experiences of South African women with recurrent breast cancer: A qualitative study

  2021cites this paper
• Reprogramming of fatty acid metabolism in breast cancer: a narrative review

  2021cites this paper
• Dietary nutrition for neurological disease therapy: Current status and future directions.

  2021cites this paper
• Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells

  2021cites this paper
• A Mechanistic Model for Genome-Scale Estimations of Metabolic Activity

  2021cites this paper
• Intravital mesoscopic fluorescence molecular tomography allows non-invasive in vivo monitoring and quantification of breast cancer growth dynamics

  2021cites this paper
• Lipid Droplets and Ferritin Heavy Chain: a Devilish Liaison in Cancer Radioresistance

  2021cites this paper
• Light and electron microscopy continuum-resolution imaging of 3D cell cultures

  2021cites this paper
• The impact of mitochondria on cancer treatment resistance

  2021cites this paper
• ROS-responsive organosilica nanocarrier for the targeted delivery of metformin against cancer with the synergistic effect of hypoglycemia.

  2021cites this paper
• Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data

  2021cites this paper
• Cycling cancer persister cells arise from lineages with distinct programs

  2021cites this paper
• Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer

  2021cites this paper
• Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy

  2021cites this paper
• Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance

  2021cites this paper
• Lipid Droplet Biosynthesis Impairment through DGAT2 Inhibition Sensitizes MCF7 Breast Cancer Cells to Radiation

  2021cites this paper
• Lipid Profiling in Cancer Diagnosis with Hand-Held Ambient Mass Spectrometry Probes: Addressing the Late-Stage Performance Concerns

  2021cites this paper
• Metabolic Stress Adaptations Underlie Mammary Gland Morphogenesis and Breast Cancer Progression

  2021cites this paper
• Metabolic memory underlying minimal residual disease in breast cancer

  2021cites this paper
• Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison

  2021cites this paper
• Long noncoding RNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in small cell lung cancer: Potential molecular panel for targeted therapy.

  2021cites this paper
• Deciphering the impact of lipid metabolism in breast cancer cells

  2021cites this paper
• Exploring the molecular targets and mechanisms of [10]-Gingerol for treating triple-negative breast cancer using bioinformatics approaches, molecular docking, and in vivo experiments

  2021cites this paper
• Dormant Cancer Cells: Molecular Features, in vitro Models, and Identification Methods

  2021cites this paper
• Metabolic Plasticity in Chemotherapy Resistance

  2020cites this paper
• Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy

  2020cites this paper
• Progestins counteract estrogens to shift breast cancer cell metabolism

  2020cites this paper
• Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer

  2020cites this paper
• Progestins counteract estrogens to shift breast cancer cells into a quiescent metabolic profile

  2020cites this paper
• Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

  2020influential citation
• Ascorbate kills breast cancer cells by rewiring metabolism via redox imbalance and energy crisis.

  2020cites this paper